Zydus Lifesciences received US approval for its generic Isotretinoin capsules, a treatment for severe acne similar to Absorica. The US market reached $115.4M in sales (MAT 2025), marking Zydus's 427th approval.
Trent Unveils Burnt Toast Brand
Shriram's Codename: The One Bengaluru's Future-Ready Gated Community
NIIF Council Approves $1B Fund, Greenfield Investments
US Boosts Tariffs on Indian Textiles
India, EAEU FTA Negotiations Launch
Market Watch: Key Stocks & Results Today
Asian Paints Q1 Profit Meets View
News that matters the most ⚡